The antibody tests build upon the work of UArizona Health Sciences and BIO5 Institute researchers. The tests will help determine how many people have been exposed to the novel coronavirus and have successfully built an immunity against it.
Audiologist and molecular biologist O’neil Guthrie, an associate professor in Northern Arizona University’s Department of Communication Sciences and Disorders, is collaborating with New Jersey-based Optigenex to conduct a pre-clinical investigation to help the body’s natural ability to repair DNA through
a novel therapy.
On the heels of a study showing how cancer can be precisely detected by a liquid biopsy blood test created by the Translational Genomics Research Institute (TGen), a new $2.1 million federal grant will enable TGen and Mayo Clinic researchers to fine-tune the system in clinical trials.
TGen North has partnered with the non-profit NARBHA Institute to advance human health through the new TGen One Health Collaborative.